The Lancet Rheumatology in conversation with
Editors at The Lancet Rheumatology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from disorders of the immune system to sex and gender in research design, the transitional care for adolescent patients with rheumatic diseases to care for undocumented immigrants, and more.
Podcasting since 2021 • 16 episodes
The Lancet Rheumatology in conversation with
Latest Episodes
Sebastian Sattui on older adults with ANCA-associated vasculitis
Dr Sebastian Sattui discusses the effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.Read the full articl...
•
25:54
Celebrating 5 years of The Lancet Rheumatology with Oliver Distler, Laura Coates, and David Liew
To celebrate 5 years of The Lancet Rheumatology, international advisory board members Oliver Distler, Laura Coates, and David Liew discuss recent progress made, challenges to overcome, and future directions in rheumatology.Read...
•
58:02
Karen Schreiber, Ian Giles, and Angela Tincani on the Pregnancy and Rheumatic Diseases Series
Dr Karen Schreiber, Professor Ian Giles, and Professor Angela Tincani discuss the Series on Pregnancy and Rheumatic Diseases, including the use of DMARDs during pregnancy, study design and conduct, and outcomes for children born to mothers with...
•
34:33
Dr Maria Tektonidou on cardiovascular risk factors in systemic lupus erythematosus
Dr Maria Tektonidou discusses the results of a cross-sectional analysis of international data on cardiovascular risk factors in systemic lupus erythematosus.
•
11:20
Rosemary Hollick on improving services for adults with rare autoimmune rheumatic diseases
Dr Rosemary Hollick, University of Aberdeen, discusses a mixed-methods study on key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases.
•
16:17